An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
<p>Apolipoprotein A-I (apoA-I) mimetic peptides have been pursued as new therapeutic agents for the treatment of atherosclerosis, yet their precise mechanism responsible for atheroprotection remains unclear. Like apoA-I itself, most of these peptides are capable of stimulating cholesterol effl...
Main Author: | Xuelei Song, Paul Fischer, Xun Chen, Charlotte Burton, Jun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2009-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v05p0637.htm |
Similar Items
-
Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01) -
Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
Published: (2014-01-01) -
SIDT2 Associates with Apolipoprotein A1 (ApoA1) and Facilitates ApoA1 Secretion in Hepatocytes
by: Alicia Sampieri, et al.
Published: (2023-09-01) -
Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
by: Irina N. Gorshkova, et al.
Published: (2023-02-01) -
Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes
by: Shuhui Wang Lorkowski, et al.
Published: (2020-04-01)